Amgen and Wyeth Pharmaceuticals reported the FDA approved expanded
marketing for Enbrel to treat arthritis associated with psoriasis. The
decision allows the companies to market Enbrel for improvement of
physical function in patients with psoriatic arthritis in addition to
the previously approved treatment for signs and conditions of the

Full Story:
MSN Money

Related Summaries